University of Crete (UOC)
Μελέτη του ρόλου της σωματοστατίνης και κορτιστατίνης στον αμφιβληστροειδή και στην ισχαιμική αμφιβληστροειδοπάθεια
Abstract
dc:descriptionThe main aim of this thesis was to investigate the neuroprotective role of somatostatin (SRIF) and its analogues against retinal ischemia. The following specific objectives were posed: to study the functional role of sst1 and sst2 somatostatin receptors, to establish a retinal model of ischemia, to ascertain the neuroprotective actions of SRIF and its analogues in this model, and to elucidate the mechanism involved in the neuroprotection. The results of this thesis suggest that activation of sst2 receptors regulates cGMP levels in the rat retina by increasing NO., suggesting an important role of the sst2 receptor in the regulation of NO/cGMP signaling. In addition, we demonstrate that SRIF release is neuronally released in rat retina. This release is regulated in a negative manner by the activation of the sst1 receptor, suggesting an autoreceptor role for SRIF. These results revealed for the first time the existence of a peptide autoreceptor. The model of chemical ischemia (CI) includes the use of sodium cyanide and iodo-acetic acid, substances that mimic conditions of anoxia and hypoglycemia. Incubation of the retina for one hour in a mixture of CI (NaCN 25mM/IAA 5mM) in conditions of 5% CO2/95% air at 37°C resulted in an attenuation of the number of amacrine cells containing cholineacetyltransfarase, tyrosine hydroxylase and NO. synthase and rodbipolar cells, as determined by immunohistochemical studies. These results were confirmed by TUNEL assays depicting extensive cell death in the CI treated samples. The use of SRIF in the CI did not protect the retina. It was demonstrated with RIA studies that under the conditions of CI SRIF was strongly metabolized. The use of of the sst2 agonists BIM23014 and MK678, and cortistatin provided neuroprotection. The increase in cGMP and NO. levels after sst2 receptor activation in the retina prompted us to study the possible neuroprotective action of NO. in the model of CI. NO. donors, NONOate and SIN-1, as well as 8-Br-cGMP protected the retina from CI. The blockade of NO. synthase and soluble guanylate cyclase reversed the neuroprotective effects of BIM23014. The results of this study suggest new roles for sst2 and sst1 receptors in the retina. They support that the model of CI could be adapted to the retina and will be useful in the study of new neuroprotective targets of retinal disease. The sst2 analogues provide retinal neuroprotection via a mechanism involving the signaling pathway NO. / cGMP.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Μαστροδήμου, Νίκη
- Mastrodimou, Niki
Subjects
dc:subject × 12- Αμφιβληστροειδική ισχαιμία
- Νευροπροστατευτική δράση σωματοστατίνης
- Μονοξείδιου του αζώτου
- Νευροπροστατευτική δράση κυκλικής μονοφωσφορικής γουανοσίνης
- Retinal ischemia
- Somatostatin's neuroprotection
- Nitric oxide (NO)
- Cyclic GMP's neuroprotection
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/26737